Breaks Categories: Stock Spotlights

WednesdayAug 19, 2020 1:22 pm

CannabisNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) Eyes ‘Infinite Development Possibilities’ in $3B Agricultural Region

Pac Roots Cannabis Corp. (CSE: PACR) will soon own and control 250 acres in the Fraser Valley Regional District, one of the most productive areas of Canada with agriculture yielding an annual economic value of more than $3 billion. Under a recent share purchase agreement with 1088070 BC. LTD, Pac Roots will soon acquire all of 1088’s issued and outstanding shares (http://cnw.fm/9xnlW). A recent article regarding this quotes Pac Roots president and CEO Patrick Elliott, who stated, “This land has no zoning restrictions and is not situated within the agricultural land reserve, which provides for infinite development possibilities. The addition of…

Continue Reading

ThursdayAug 13, 2020 3:04 pm

CannabisNewsBreaks – Why Pac Roots Cannabis Corp. (CSE: PACR) Is ‘One to Watch’

Pac Roots Cannabis Corp. (CSE: PACR) is a Canadian-based company that leverages a genetics-focused approach in producing premium-quality strains and products. A recent article discussing Pac Roots reads, “The company began operations in 2012, with activities primarily directed toward exploration and development of mineral properties in Canada. Today, it is focused on cannabis and hemp cultivation, leveraging high-end genetics and specialized cultivars to produce top-quality products. Pac Roots has announced multiple promising initiatives in recent months, including its formation of an outdoor, premium-hemp joint venture with partner Rock Creek Farms in British Columbia and its agreement to acquire all issued…

Continue Reading

TuesdayAug 04, 2020 12:43 pm

CannabisNewsBreaks – Pure Extracts Corp. to Drive Product Innovation with Leading-Edge Team, Technology

Pure Extracts, a private, plant-based extraction company with a new vertical in functional mushrooms, leverages a team of qualified experts and cutting-edge technology. The company’s distinction on a path toward opportunity was highlighted in a recent article, which reads, “Pure Extracts, on the other hand, is ideally positioned to enter the space as an experienced producer. With a team of qualified experts and cutting-edge extraction technology, the company is set up for long-term strategic distribution and product innovation. Located near Whistler, British Columbia, the company’s facility is built for EU-GMP certification, which allows for international sales and ensures the production…

Continue Reading

FridayJun 19, 2020 12:54 pm

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Reports Encouraging Q1 2020 Financial, Operational Results

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp-branded products company in the United States, recently reported unaudited financial and operational results for Q1 2020 (http://cnw.fm/7raXQ). An article discussing the company further reads, “‘Our first-quarter financial results paint the picture of a much healthier business than previous quarters,’ he continued. ‘But the work is far from done. In 2020, we are focused on leveraging our core capabilities to create capital-efficient growth through known distribution channels.’ . . . According to the report filed with the Canadian Securities Exchange (‘CSE’), net revenues for the company rose from $3.2 million for…

Continue Reading

ThursdayJun 04, 2020 2:14 pm

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Names New CEO

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human-optimization sciences company with an emphasis on ketamine and psychedelic medicine, recently named Dr. Roger McIntyre as chief executive officer. An article discussing the company reads, “In his new role, Dr. Roger McIntyre brings impressive experience in the ketamine and psychedelic medicine space, a key focus area for Champignon. . . . ‘My overarching aim as chief executive officer is to establish Champignon as the apotheosis of integrated ketamine treatment delivery and the commercialization of our own IP psychedelic-based treatments,’ McIntyre stated in a news release. ‘The clinical infrastructure, complementary asset…

Continue Reading

MondayMay 18, 2020 1:53 pm

CannabisNewsBreaks – Supreme Cannabis Company Inc.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) 7ACRES and Blissco Complete Construction, Secure Full Licenses

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently announced that it has completed construction and obtained full licensing for two of its key assets: the 440,000-square-foot, state-of-the-art 7ACRES cultivation plant and the 12,000-square-foot Blissco extraction facility. An article discussing the company reads, “This milestone step makes Supreme one of the few Canadian producers that operates fully constructed and licensed cultivation and extraction facilities. . . . In March, British-Columbia-based Blissco received Health Canada’s approval on its final licensing amendments, and Supreme announced plans to conduct all extraction in-house from the now fully licensed facility (http://cnw.fm/Tn698). The licensing announcement…

Continue Reading

FridayMay 15, 2020 3:20 pm

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) CEO Outlines Critical Company Objectives

Plus Products (CSE: PLUS) (OTCQX: PLPRF) co-founder and CEO Jake Heimark recently outlined three critical objectives the company will be focusing on throughout the coming year (http://cnw.fm/QVv51). A recent article discussing the letter reads, “‘We have set three critical objectives as a company over the next four quarters,’ he stated. ‘1) to ensure the safety and health of our employees and customers, 2) to continue to establish ourselves as a clear, long-term leader in the California edibles space and 3) to become a cash-flow positive business.’ . . . Heimark then went on to explain that PLUS is ‘capitalized with enough…

Continue Reading

FridayApr 24, 2020 11:55 am

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Launches New CBDRelief Brand Targeting Underserved Market Sector

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a California-based cannabis-products company, recently launched its PLUS CBDRelief brand. The new line of products is comprised of two high-CBD, low-THC gummies designed to address pain, stress and anxiety (http://cnw.fm/KL07j). An article discussing the company reads, “The product line currently includes two products: PLUS CBDRelief 9:1 Tropical Mango with 9 mg of CBD and 1 mg of THC per serving and PLUS CBDRelief 18:1 Tart Cherry with 18 mg of CBD and 1 mg of THC per serving. The PLUS CBDRelief cannabis-infused gummies are expected to be available statewide in coming weeks. . . .…

Continue Reading

FridayApr 17, 2020 2:00 pm

CannabisNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Completes Landmark Shipment of Premium Medical Cannabis Products to Israel

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently completed a landmark shipment containing Supreme Cannabis’ premium medical cannabis product from Canada to Israel (http://cnw.fm/8kJWr). An article discussing the company reads, “Supreme Cannabis interim president and CEO Colin Moore reported that the transaction, which was made possible through a partnership with Breath of Life International (BOL Pharma), represents a new international revenue opportunity for Supreme Cannabis and ‘builds Truverra’s global medical brand in one of the most sophisticated medical cannabis markets in the world.’ . . .‘With the support of BOL Pharma, we navigated both Canada and Israel’s complex…

Continue Reading

ThursdayApr 09, 2020 11:33 am

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Aims to Support Mental Health, Develop Improved Treatments Using Psilocybin Mushrooms

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human-optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, offers a timely line of organic, non-GMO and vegan-certified products. In 2019, Johns Hopkins launched a center for psychedelic research backed by private funders (http://cnw.fm/1lTHD). A recent article discussing the company reads, “The focus of John Hopkin’s studies will be on the affect psychedelics have on behavior, brain function, learning and memory, and the brain’s biology and mood. New therapies and the effectiveness of psilocybin are…

Continue Reading